Jacques Servier, founder and president of Lab Servier, dies aged 92
French independent drugmaker Laboratories Servier announced that its founder and president, Jacques Servier, has died at the age of 92.
The spirit, the motivation and the mission of this exceptional personality, whose whole life revolved around the research of innovative medicines, will continue to exist in the priorities given to scientific research and human values in the enterprise he created exactly 60 years ago, the company stated.
Dr Servier planned for the long term durability of his research group by organizing it in the form of a Foundation at the beginning of the nineteen-eighties. The dispositions concerning the structure, the directors and the new president will be announced shortly according to his instructions, it was noted.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze